| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $14,912,550 ) (Continued on the next page) |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | F31DK139601 | The reninness score: integrative analysis of multi-omic data to define renin cell identity | 000 | 2 | NIH | 12/9/2025 | $40,760 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R35GM144130 | Synthesis, secretion and assembly of extracellular complex carbohydrates in Gram-negative bacteria | 000 | 5 | NIH | 12/16/2025 | $473,161 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R35GM152065 | Rapid Synthesis of Topologically Complex Molecules with Tungsten Dearomatization Agents | 001 | 3 | NIH | 1/14/2026 | $79,310 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R35GM152065 | Rapid Synthesis of Topologically Complex Molecules with Tungsten Dearomatization Agents | 000 | 3 | NIH | 1/8/2026 | $343,690 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R37CA248434 | Evaluating Digital Micro-Interventions to Reduce Distress and Increase Wellbeing in Breast Cancer Survivors | 000 | 6 | NIH | 1/14/2026 | $467,203 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R35GM152130 | ARFs, ORPs and the control of cell migration | 000 | 3 | NIH | 12/11/2025 | $363,375 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01NS138119 | Mechanisms Underlying the Pathogenesis of SEL1L-HRD1 ERAD Disease Variants | 000 | 2 | NIH | 1/14/2026 | $574,407 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01NS126265 | Novel immunotherapeutic potential of DGKalpha inhibition for glioblastoma | 000 | 4 | NIH | 12/10/2025 | $359,097 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01NS126594 | Respiration and Generalized Epilepsies | 000 | 5 | NIH | 1/14/2026 | $472,438 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R21DC021023 | Development of an MRI Guided Machine Learning Algorithm to Assess the Velopharyngeal Mechanism | 000 | 3 | NIH | 12/11/2025 | $181,688 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R21CA297427 | Elucidate the role of B/T cell-enriched immune aggregates in immune surveillance against TNBC | 000 | 2 | NIH | 12/5/2025 | $169,879 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R21AG092022 | 3-hydroxybutyrate: an unexpected longevity factor in yeast | 000 | 2 | NIH | 12/3/2025 | $196,543 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01NS122834 | Role of brainstem cardiorespiratory neurons in SUDEP | 000 | 5 | NIH | 1/14/2026 | $359,074 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01DK128077 | Novel role of endoplasmic reticulum-associated degradation in iron metabolism | 000 | 5 | NIH | 12/4/2025 | $403,750 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01DK132786 | Mechanisms of ER-Protein Quality Control in Podocytes | 000 | 4 | NIH | 12/19/2025 | $402,984 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01EB035430 | Next-Generation ATP-Independent Luciferases, Luciferins, and Bioluminescent Calcium Indicators | 000 | 3 | NIH | 1/13/2026 | $369,036 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01CA259573 | Role of UTX condensation in chromatin regulation | 000 | 5 | NIH | 12/17/2025 | $303,581 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01CA269594 | Targeting AVIL, a novel oncogene in rhabdomyosarcoma | 000 | 4 | NIH | 12/18/2025 | $453,284 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01CA256199 | A premalignant chronology of cell-state variability in basal-like breast cancer | 000 | 5 | NIH | 12/11/2025 | $589,939 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01CA279681 | Function of the METTL3-NUP93 complex-mediated nuclear export of m6A-modified mRNAs in castration-resistant prostate cancer. | 000 | 3 | NIH | 1/7/2026 | $382,418 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01CA279134 | MR Image-Guided Drug Delivery to Cerebral Cavernous Malformations with Focused Ultrasound | 000 | 3 | NIH | 12/16/2025 | $553,784 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01CA288612 | Targeting tumor-specific epitope for imaging and therapy for mesothelioma | 000 | 2 | NIH | 12/17/2025 | $612,666 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01DK120330 | Novel role of hepatic SEL1L-HRD1 ERAD in bile acid metabolism | 000 | 8 | NIH | 12/30/2025 | $683,673 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01AI137080 | Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults | 000 | 9 | NIH | 1/2/2026 | $616,730 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01AI124214 | Role of Type 2 Immunity in Innate Protection from C. difficile | 000 | 10 | NIH | 1/8/2026 | $564,456 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01AI097312 | Survival of Neisseria gonorrhoeae after primary human neutrophil challenge | 000 | 12 | NIH | 11/25/2025 | $552,619 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01AI179778 | Host factors in shigellosis | 000 | 3 | NIH | 11/24/2025 | $702,315 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01AI183581 | Biophysical and functional coupling of protein condensates to ordered lipid domains in T-cells | 000 | 2 | NIH | 12/10/2025 | $663,178 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01AR078888 | Deciphering Macrophage Phenotype and Function in Disc Herniation and associated Back/leg Pain | 000 | 4 | NIH | 12/24/2025 | $410,601 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R00AI180425 | Breadth and mechanism of Wolbachia-based inhibition of fungal infection in Drosophila | 000 | 3 | NIH | 12/31/2025 | $248,575 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R00AR080207 | Regulation of lupus pathogenesis through modulation of thymic development of pathobiont-specific T cells | 000 | 5 | NIH | 12/24/2025 | $224,099 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01AG090337 | CD38, T cells and post viral lung sequelae during aging | 000 | 2 | NIH | 1/12/2026 | $561,928 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01AG091577 | Epitranscriptomic Mechanism in pathogenesis of Alzheimer’s disease | 000 | 2 | NIH | 12/23/2025 | $650,777 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01AG080773 | Mevalonate Pathway Regulation of Astrocyte ApoE | 000 | 4 | NIH | 12/15/2025 | $411,774 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R37CA269776 | Optimizing psychosocial intervention for breast cancer-related sexual morbidity: A factorial trial using the National Cancer Institute Community Oncology Research Program (NCORP) network | 000 | 4 | NIH | 12/11/2025 | $531,855 |
| | 2026 | 2026 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | F30HD111307 | Localized mitochondrial metabolic activity in Xenopus mesendoderm cells undergoing collective cell migration | 000 | 3 | NIH | 12/5/2025 | $54,538 |
| | 2026 | 2025 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | UH3NS123308 | A staged, comprehensive investigation for developing insular deep brain stimulation to treat refractory chronic pain | 000 | 3 | NIH | 11/20/2025 | $0 |
| | 2026 | 2025 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | UH3NS123308 | A staged, comprehensive investigation for developing insular deep brain stimulation to treat refractory chronic pain | 000 | 3 | NIH | 11/20/2025 | $0 |
| | 2026 | 2025 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | UG3NS131532 | Ketamine Add-On for Established Status Epilepticus Treatment Trial (KESETT) | 000 | 1 | NIH | 11/14/2025 | $0 |
| | 2026 | 2025 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | UG3NS123191 | Minimally Invasive Cerebral Blood Flow and Oxygenation Monitoring for Intracranial Hypertension | 000 | 3 | NIH | 12/18/2025 | $0 |
| | 2026 | 2025 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | U54CA274499 | Systems Analysis of Stress-adapted Cancer Organelles (SASCO) Center | 000 | 4 | NIH | 12/19/2025 | $0 |
| | 2026 | 2025 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | T32HL007849 | Cardiovascular Surgery Training Program | 000 | 25 | NIH | 12/3/2025 | $0 |
| | 2026 | 2025 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R21MH137636 | Non-invasive targeting of perineuronal nets for treating excessive repetitive behavior | 000 | 1 | NIH | 11/25/2025 | $0 |
| | 2026 | 2025 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R37AI097312 | Survival of Neisseria gonorrhoeae after primary human neutrophil challenge | 000 | 11 | NIH | 1/9/2026 | $0 |
| | 2026 | 2025 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01HL162925 | Systems Pharmacology Model of Cardiac Hypertrophy | 000 | 4 | NIH | 1/13/2026 | $0 |
| | 2026 | 2025 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01HL159159 | Decoding the Molecular and Cellular Mechanisms of Mutant KRAS-driven Brain Arteriovenous Malformations | 000 | 4 | NIH | 10/27/2025 | $0 |
| | 2026 | 2025 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01HL155547 | Mycobacterial Lung Diseases in Virginia: sequencing and clinical determinants of relapse and outcome | 000 | 5 | NIH | 10/23/2025 | $0 |
| | 2026 | 2025 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01HL155523 | Imaging sodium and lymphatics in lymphedema | 000 | 5 | NIH | 10/20/2025 | $0 |
| | 2026 | 2025 | RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA | 1001 EMMET ST N | CHARLOTTESVILLE | VA | 22903-4833 | CHARLOTTESVILLE CITY | USA | R01HL160665 | Computational and Experimental Modeling of Cardiomyocyte Proliferation | 000 | 4 | NIH | 10/24/2025 | $0 |
|
